sábado, 20 de mayo de 2023

KVD900, an oral on-demand treatment for hereditary angioedema: Phase 1 study results - Journal of Allergy and Clinical Immunology

KVD900, an oral on-demand treatment for hereditary angioedema: Phase 1 study results - Journal of Allergy and Clinical Immunology

No hay comentarios:

Publicar un comentario